Developer docs
API playgroundTry for free, no card

Search company profiles

Jai Research Foundation

Full company profile

uuid004pb2q

Namestring
Jai Research Foundation
Legal namestring
Jai Research Foundation
Websiteurl
jrfonline.com
Company typeenum
Private
Founded yearint
1977
Descriptiontext

Jai Research Foundation (JRF) is a pre-clinical Contract Research Organization founded in 1977 and headquartered in Vapi, Gujarat, India. The firm delivers GLP-compliant contract research services spanning toxicology, product chemistry, analytical chemistry, residue chemistry, ecotoxicology, and environmental fate and metabolism studies. Its client base is vertically diversified across six regulated end-markets: pharmaceuticals and biopharmaceuticals, crop care / agrochemicals, specialty chemicals under EU REACH, biocides, cosmetics, and microbial pesticides. Operations are anchored on a 158,000+ sq ft integrated campus featuring a Barrier Maintained Rodent vivarium and a Class 10,000 in vitro laboratory, supported by 106 employees.

JRF's business model is B2B professional services, with project-based quote pricing rather than subscription or recurring-revenue mechanics. Service delivery is gated by a deep regulatory credential stack — AAALAC accreditation, OECD GLP compliance via NGCMA, CPCSEA recognition, NRC/BARC approval for radioactive chemicals handling, DST scientific recognition, FDA FEI registration (3014694901), and OLAW assurance (F22-00563) — which collectively allow study outputs to be accepted by regulators in major markets. The firm has extended its commercial reach internationally through JRF International Ltd. (UK, 1998) and JRF America (USA, 2008), giving it a three-jurisdiction footprint (India-UK-US). It also markets a service line called Biocelerate positioned around accelerated-study innovation, though specific technical differentiators behind the brand are not disclosed.

As a privately held entity with no disclosed funding rounds, executive team details, named customers, or financial statements, JRF operates with limited external visibility. Its competitive position rests on a combination of regulatory accreditation depth, multi-vertical load-balancing, Indian cost-arbitrage, and specialized infrastructure that newer entrants would require years to replicate.

Short descriptiontext

Jai Research Foundation is an India-based pre-clinical CRO founded in 1977 delivering GLP-compliant toxicology, ecotoxicology, residue, and environmental fate studies to pharmaceutical, agrochemical, REACH, biocide, cosmetics, and microbial pesticide sponsors across India, the UK, and the US.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersVapi, India
HQ citystring
Vapi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
preclinical contract research, GLP toxicology testing, regulatory safety studies, ecotoxicology testing services, environmental fate analysis
Industry3 codes
1Toxicology & Safety Assessment CROs (GLP)
CodeHLAGAAACPrimaryYes
2Central Laboratory & Clinical Trial Testing CROs
CodeHLAGAAAEPrimaryNo
3Regulatory Consulting & Compliance Program Management (FDA/USDA/EFSA)
CodeAFALADACPrimaryNo
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
  • Services-Medical Laboratories8071
Product category
Preclinical Contract Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

JRF generates revenue through providing contract research services in toxicology, chemistry, environmental fate, ecotoxicology, and related scientific testing for pharmaceutical, crop care, specialty chemicals, biocides, and cosmetics companies. Services are billed per study/project with compliance with various regulatory guidelines (OECD GLP, FDA, etc.).

jrfglobal.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Jai Research Foundation (JRF) is a pre-clinical Contract Research Organization (CRO) that delivers GLP-compliant toxicology, product chemistry, analytical and residue chemistry, ecotoxicology, and environmental fate studies for pharmaceutical, bio-pharmaceutical, crop care, REACH/specialty chemicals, biocides, cosmetics, and microbial pesticides clients. It operates from a 158,000+ sq. ft. facility in Vapi, Gujarat, India with a Barrier Maintained Rodent facility and Class 10,000 in vitro clean room, and serves global clients through affiliated entities in the UK and USA.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Jai Research Foundation is a pre-clinical Contract Research Organization (CRO) offering a comprehensive portfolio of laboratory testing and research services across six primary service verticals: Pharma/Bio Pharma, Crop Care, REACH (Specialty Chemicals/Industrial Biotech), Biocides, Cosmetics, and Microbial Pesticides. The company operates from a 158,000+ Sq. Ft. facility in Vapi, Gujarat, India, with specialized laboratories for Toxicology, Product Chemistry, Analytical and Residue Chemistry, Ecotoxicology, and Environmental Fate and Metabolism studies. Services are conducted in compliance with global regulatory frameworks including OECD GLP, FDA, EMA, and various international guidelines (OECD, ICH, GCR/KCR, Schedule Y, OCSPP/OPPTS). The organization offers integrated service modules spanning from early-stage drug development evaluation (IND/NDA/ANDA) through safety pharmacology, DMPK/ADME, genotoxicity, and environmental risk assessment, enabling clients to meet regulatory submission requirements across multiple jurisdictions. The portfolio includes Biocelerate for innovation-focused pharma services, comprehensive toxicology testing programs (acute, chronic, subchronic, DART), analytical services (bioanalyticals, method development/validation), chemical characterization, and specialized in vitro alternative assays for reduced animal testing. Environmental services include ecotoxicology, environmental fate studies, and operator exposure assessments for crop protection products.

Product and service7 records
1Pharma / Bio Pharma Services
2Crop Care Services
CategoryPreclinical Contract Research
Description

Regulatory toxicology, chemistry, and environmental testing services for agrochemical and crop protection product registration, including Acute and Chronic Toxicity, Subchronic Inhalation, Genotox, In vitro Alternative Assays, In vitro Dermal Absorption, Endocrine Disruptor Screening, DART, Method Development, 5 Batch Analysis, Physico-chemical Analysis, Environmental Fate, Ecotoxicology, Operator Exposure, Efficacy and Residue Field Trials, and Crop Residue Characterization & Analysis.

3REACH (Specialty Chemicals / Industrial Biotech) Services
CategoryPreclinical Contract Research
Description

REACH regulation compliance testing and chemical safety assessment for specialty chemicals and industrial biotechnology products, including Acute and Chronic Toxicity, Subchronic Inhalation, In vitro Alternative Assays, Genotox, Endocrine Disruptor Screening, DART, Chemical Characterization, Method Development and Validation, Physico-chemical Analysis, Environmental Fate, Ecotoxicology, Fish Early-life Stage Toxicity Test, and Custom Synthesis.

4Biocides Services
CategoryPreclinical Contract Research
Description

Toxicology and regulatory testing services for biocidal product registration, including Acute and Chronic Toxicity, Subchronic Inhalation, In vitro Alternative Assays, Genotox, Endocrine Disruptor Screening, DART, Method Development and Validation, Chemical Characterization, Physico-chemical Analysis, Environmental Fate, and Ecotoxicology.

5Cosmetics Services
CategoryPreclinical Contract Research
Description

In vitro safety testing services for cosmetic products and ingredients, including In vitro Dermal Absorption, In vitro Skin Corrosion, In vitro Eye Irritation, In vitro Skin Irritation, In vitro Skin Sensitization, Phototoxicity, Bovine Corneal Opacity and Permeability (BCOP), In vitro Genotox, and Method Development and Validation, providing alternatives to animal testing.

6Microbial Pesticides Services
CategoryPreclinical Contract Research
Description

Specialized testing and evaluation services for microbial-based pesticide products to support registration, safety, and efficacy assessments.

7Biocelerate
CategoryPreclinical Contract Research
Description

A branded service offering under the Pharma/Bio Pharma vertical that leverages innovation for accelerated drug development and evaluation for pharmaceutical and bio-pharmaceutical clients.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2008-01-01
Description

Collaboration established in 2008 with JRF America in the USA, providing North American market access and client support for the contract research organization services.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on1998-01-01
Description

Collaboration established in 1998 with JRF International Ltd. based in the UK, enabling JRF to serve international clients and expand global presence in the contract research organization market.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

India-based CRO/CDMO offering toxicology, DMPK, and process chemistry services. Comparable in scale, India-based preclinical service mix, and pharma sponsor base.

TypeDirect peer
Description

India-based integrated CRO offering preclinical toxicology, DMPK, and safety assessment services to global pharma and agrochemical sponsors. Closest direct peer given overlapping GLP toxicology, regulatory accreditation, and India-cost-arbitrage positioning.

TypeBroad incumbent
Description

Global lab testing giant with extensive agrochemical, REACH chemical, and ecotoxicology testing operations. Competes with JRF in REACH, crop care residue, and ecotoxicology verticals but at vastly larger scale and broader service scope.

TypeBroad incumbent
Description

Global CRO offering drug discovery, preclinical toxicology, DMPK, and safety pharmacology with major China and UK operations. Direct competitor in preclinical safety assessment and bioanalytical services.

TypeDirect peer
Description

Bengaluru-headquartered preclinical CRO specializing in GLP toxicology, safety pharmacology, and regulatory studies. Closely comparable niche player in India preclinical toxicology with overlapping OECD GLP positioning.

TypeBroad incumbent
Description

China-headquartered global CRO/CDMO with preclinical toxicology and DMPK capabilities. Competes with JRF for global pharma outsourcing contracts and has scaled preclinical capacity aggressively in Asia.

TypeDirect peer
Description

Indian CRO providing preclinical toxicology, analytical chemistry, and bioanalytical services to pharma, biopharma, and agrochemical clients. Direct peer in regulatory testing verticals with overlapping OECD GLP and NABL-accredited offerings.

TypeBroad incumbent
Description

Global CRO with extensive preclinical toxicology, safety pharmacology, and central laboratory capabilities. Competes with JRF in early-stage safety assessment for large pharma sponsors.

TypeBroad incumbent
Description

Global preclinical CRO leader offering safety assessment, DART, and toxicology services through audited facilities worldwide. Direct competitor in pharma safety assessment with much larger global footprint.

TypeDirect peer
Description

India-headquartered preclinical and discovery CRO with extensive toxicology, DMPK, and safety pharmacology services. Direct comparable in scale, regulatory accreditation profile, and global pharma sponsor mix.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Jai Research Foundation

Preclinical Contract Research Servicesjrfonline.com

Jai Research Foundation is an India-based pre-clinical CRO founded in 1977 delivering GLP-compliant toxicology, ecotoxicology, residue, and environmental fate studies to pharmaceutical, agrochemical, REACH, biocide, cosmetics, and microbial pesticide sponsors across India, the UK, and the US.

What Jai Research Foundation does

Jai Research Foundation (JRF) is a pre-clinical Contract Research Organization founded in 1977 and headquartered in Vapi, Gujarat, India. The firm delivers GLP-compliant contract research services spanning toxicology, product chemistry, analytical chemistry, residue chemistry, ecotoxicology, and environmental fate and metabolism studies. Its client base is vertically diversified across six regulated end-markets: pharmaceuticals and biopharmaceuticals, crop care / agrochemicals, specialty chemicals under EU REACH, biocides, cosmetics, and microbial pesticides. Operations are anchored on a 158,000+ sq ft integrated campus featuring a Barrier Maintained Rodent vivarium and a Class 10,000 in vitro laboratory, supported by 106 employees.

JRF's business model is B2B professional services, with project-based quote pricing rather than subscription or recurring-revenue mechanics. Service delivery is gated by a deep regulatory credential stack — AAALAC accreditation, OECD GLP compliance via NGCMA, CPCSEA recognition, NRC/BARC approval for radioactive chemicals handling, DST scientific recognition, FDA FEI registration (3014694901), and OLAW assurance (F22-00563) — which collectively allow study outputs to be accepted by regulators in major markets. The firm has extended its commercial reach internationally through JRF International Ltd. (UK, 1998) and JRF America (USA, 2008), giving it a three-jurisdiction footprint (India-UK-US). It also markets a service line called Biocelerate positioned around accelerated-study innovation, though specific technical differentiators behind the brand are not disclosed.

As a privately held entity with no disclosed funding rounds, executive team details, named customers, or financial statements, JRF operates with limited external visibility. Its competitive position rests on a combination of regulatory accreditation depth, multi-vertical load-balancing, Indian cost-arbitrage, and specialized infrastructure that newer entrants would require years to replicate.

Jai Research Foundation firmographics

Firmographics
Name
Jai Research Foundation
Legal name
Jai Research Foundation
Website
https://jrfonline.com
Company type
Private
Founded year
1977
Operating status
Operating
Headcount range
101–250 employees
Short description
Jai Research Foundation is an India-based pre-clinical CRO founded in 1977 delivering GLP-compliant toxicology, ecotoxicology, residue, and environmental fate studies to pharmaceutical, agrochemical, REACH, biocide, cosmetics, and microbial pesticide sponsors across India, the UK, and the US.
Ownership category
akta.pro rank

Jai Research Foundation industry classification

Industry
Product category
Preclinical Contract Research Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Services-Medical Laboratories (8071)
akta.pro primary industry
Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)
akta.pro secondary industries
Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Regulatory Consulting & Compliance Program Management (FDA/USDA/EFSA) (AFALADAC)

Keywords

  • Preclinical contract research
  • GLP toxicology testing
  • Regulatory safety studies
  • Ecotoxicology testing services
  • Environmental fate analysis

Where Jai Research Foundation is headquartered

Location

Headquarters

HQ city
Vapi
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Jai Research Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Contract Research Services: JRF generates revenue through providing contract research services in toxicology, chemistry, environmental fate, ecotoxicology, and related scientific testing for pharmaceutical, crop care, specialty chemicals, biocides, and cosmetics companies. Services are billed per study/project with compliance with various regulatory guidelines (OECD GLP, FDA, etc.).

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Jai Research Foundation product offering

Product offering

Core offering

Jai Research Foundation (JRF) is a pre-clinical Contract Research Organization (CRO) that delivers GLP-compliant toxicology, product chemistry, analytical and residue chemistry, ecotoxicology, and environmental fate studies for pharmaceutical, bio-pharmaceutical, crop care, REACH/specialty chemicals, biocides, cosmetics, and microbial pesticides clients. It operates from a 158,000+ sq. ft. facility in Vapi, Gujarat, India with a Barrier Maintained Rodent facility and Class 10,000 in vitro clean room, and serves global clients through affiliated entities in the UK and USA.

Product overview

Jai Research Foundation is a pre-clinical Contract Research Organization (CRO) offering a comprehensive portfolio of laboratory testing and research services across six primary service verticals: Pharma/Bio Pharma, Crop Care, REACH (Specialty Chemicals/Industrial Biotech), Biocides, Cosmetics, and Microbial Pesticides. The company operates from a 158,000+ Sq. Ft. facility in Vapi, Gujarat, India, with specialized laboratories for Toxicology, Product Chemistry, Analytical and Residue Chemistry, Ecotoxicology, and Environmental Fate and Metabolism studies. Services are conducted in compliance with global regulatory frameworks including OECD GLP, FDA, EMA, and various international guidelines (OECD, ICH, GCR/KCR, Schedule Y, OCSPP/OPPTS). The organization offers integrated service modules spanning from early-stage drug development evaluation (IND/NDA/ANDA) through safety pharmacology, DMPK/ADME, genotoxicity, and environmental risk assessment, enabling clients to meet regulatory submission requirements across multiple jurisdictions. The portfolio includes Biocelerate for innovation-focused pharma services, comprehensive toxicology testing programs (acute, chronic, subchronic, DART), analytical services (bioanalyticals, method development/validation), chemical characterization, and specialized in vitro alternative assays for reduced animal testing. Environmental services include ecotoxicology, environmental fate studies, and operator exposure assessments for crop protection products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharma / Bio Pharma Services
  • Crop Care Services Regulatory toxicology, chemistry, and environmental testing services for agrochemical and crop protection product registration, including Acute and Chronic Toxicity, Subchronic Inhalation, Genotox, In vitro Alternative Assays, In vitro Dermal Absorption, Endocrine Disruptor Screening, DART, Method Development, 5 Batch Analysis, Physico-chemical Analysis, Environmental Fate, Ecotoxicology, Operator Exposure, Efficacy and Residue Field Trials, and Crop Residue Characterization & Analysis.
  • REACH (Specialty Chemicals / Industrial Biotech) Services REACH regulation compliance testing and chemical safety assessment for specialty chemicals and industrial biotechnology products, including Acute and Chronic Toxicity, Subchronic Inhalation, In vitro Alternative Assays, Genotox, Endocrine Disruptor Screening, DART, Chemical Characterization, Method Development and Validation, Physico-chemical Analysis, Environmental Fate, Ecotoxicology, Fish Early-life Stage Toxicity Test, and Custom Synthesis.
  • Biocides Services Toxicology and regulatory testing services for biocidal product registration, including Acute and Chronic Toxicity, Subchronic Inhalation, In vitro Alternative Assays, Genotox, Endocrine Disruptor Screening, DART, Method Development and Validation, Chemical Characterization, Physico-chemical Analysis, Environmental Fate, and Ecotoxicology.
  • Cosmetics Services In vitro safety testing services for cosmetic products and ingredients, including In vitro Dermal Absorption, In vitro Skin Corrosion, In vitro Eye Irritation, In vitro Skin Irritation, In vitro Skin Sensitization, Phototoxicity, Bovine Corneal Opacity and Permeability (BCOP), In vitro Genotox, and Method Development and Validation, providing alternatives to animal testing.
  • Microbial Pesticides Services Specialized testing and evaluation services for microbial-based pesticide products to support registration, safety, and efficacy assessments.
  • Biocelerate A branded service offering under the Pharma/Bio Pharma vertical that leverages innovation for accelerated drug development and evaluation for pharmaceutical and bio-pharmaceutical clients.

Companies that use Jai Research Foundation

Customer profile

Segments6 records

Ideal customer profiles5 records

Jai Research Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Jai Research Foundation partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • JRF AmericacoreStrategic or Co-development Partner · 1 January 2008Collaboration established in 2008 with JRF America in the USA, providing North American market access and client support for the contract research organization services.
  • JRF International Ltd.coreStrategic or Co-development Partner · 1 January 1998Collaboration established in 1998 with JRF International Ltd. based in the UK, enabling JRF to serve international clients and expand global presence in the contract research organization market.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Jai Research Foundation competitors and assessment

Company assessment

Direct peers

  • Sai Life Sciences: India-based CRO/CDMO offering toxicology, DMPK, and process chemistry services. Comparable in scale, India-based preclinical service mix, and pharma sponsor base.
  • Syngene International: India-based integrated CRO offering preclinical toxicology, DMPK, and safety assessment services to global pharma and agrochemical sponsors. Closest direct peer given overlapping GLP toxicology, regulatory accreditation, and India-cost-arbitrage positioning.
  • Bioneeds India: Bengaluru-headquartered preclinical CRO specializing in GLP toxicology, safety pharmacology, and regulatory studies. Closely comparable niche player in India preclinical toxicology with overlapping OECD GLP positioning.
  • Vimta Labs: Indian CRO providing preclinical toxicology, analytical chemistry, and bioanalytical services to pharma, biopharma, and agrochemical clients. Direct peer in regulatory testing verticals with overlapping OECD GLP and NABL-accredited offerings.
  • Aragen Life Sciences (formerly GVK Biosciences): India-headquartered preclinical and discovery CRO with extensive toxicology, DMPK, and safety pharmacology services. Direct comparable in scale, regulatory accreditation profile, and global pharma sponsor mix.

Broad incumbents

  • Eurofins Scientific: Global lab testing giant with extensive agrochemical, REACH chemical, and ecotoxicology testing operations. Competes with JRF in REACH, crop care residue, and ecotoxicology verticals but at vastly larger scale and broader service scope.
  • Pharmaron: Global CRO offering drug discovery, preclinical toxicology, DMPK, and safety pharmacology with major China and UK operations. Direct competitor in preclinical safety assessment and bioanalytical services.
  • WuXi AppTec: China-headquartered global CRO/CDMO with preclinical toxicology and DMPK capabilities. Competes with JRF for global pharma outsourcing contracts and has scaled preclinical capacity aggressively in Asia.
  • Labcorp Drug Development (formerly Covance): Global CRO with extensive preclinical toxicology, safety pharmacology, and central laboratory capabilities. Competes with JRF in early-stage safety assessment for large pharma sponsors.
  • Charles River Laboratories: Global preclinical CRO leader offering safety assessment, DART, and toxicology services through audited facilities worldwide. Direct competitor in pharma safety assessment with much larger global footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Jai Research Foundation social profiles

Digital presence

Jai Research Foundation compliance and trust

Trust signal

Compliance5 records

Jai Research Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Jai Research Foundation leadership team

Management profile

Number of profiles

Jai Research Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Jai Research Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jai Research Foundation

What does Jai Research Foundation do?

Jai Research Foundation (JRF) is a pre-clinical Contract Research Organization (CRO) that delivers GLP-compliant toxicology, product chemistry, analytical and residue chemistry, ecotoxicology, and environmental fate studies for pharmaceutical, bio-pharmaceutical, crop care, REACH/specialty chemicals, biocides, cosmetics, and microbial pesticides clients. It operates from a 158,000+ sq. ft. facility in Vapi, Gujarat, India with a Barrier Maintained Rodent facility and Class 10,000 in vitro clean room, and serves global clients through affiliated entities in the UK and USA.

Is Jai Research Foundation a public or private company?

Jai Research Foundation is a private company. It is classified as unknown and is currently operating.

When was Jai Research Foundation founded?

Jai Research Foundation was founded in 1977. It employs 101 to 250 people.

Where is Jai Research Foundation based?

Jai Research Foundation is headquartered in Vapi, India, in the Asia region.

How does Jai Research Foundation make money?

One revenue line is on record: contract Research Services.

Who are Jai Research Foundation's main competitors?

Direct peers on record are Sai Life Sciences, Syngene International, Bioneeds India, Vimta Labs and Aragen Life Sciences (formerly GVK Biosciences). Broad incumbents are Eurofins Scientific, Pharmaron, WuXi AppTec, Labcorp Drug Development (formerly Covance) and Charles River Laboratories.

Does Jai Research Foundation have an API?

No public API is recorded for Jai Research Foundation.

What industry is Jai Research Foundation in?

Jai Research Foundation's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales